These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 13853509)

  • 21. [On the stereochemistry of adrenergic compounds: the synthesis of cis- and trans-2-amino-1-tetralol].
    ZYMALKOWSKI F; RIMEK HJ
    Arch Pharm Ber Dtsch Pharm Ges; 1961 Sep; 294/66():581-7. PubMed ID: 13789061
    [No Abstract]   [Full Text] [Related]  

  • 22. Kinetics of the specific base-catalyzed hydrolysis of naphazoline.
    STERN MJ; KING LD; MARCUS AD
    J Am Pharm Assoc Am Pharm Assoc; 1959 Nov; 48():641-7. PubMed ID: 13854944
    [No Abstract]   [Full Text] [Related]  

  • 23. [Some microcrystal tests on naphazoline].
    van der WEGEN T
    Pharm Weekbl; 1962 Aug; 97():664-6. PubMed ID: 14005556
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dopexamine hydrochloride. A new synthetic sympathomimetic].
    Pedersen NA; Bang LE; Petersen PM
    Ugeskr Laeger; 1991 May; 153(22):1600-2. PubMed ID: 1676196
    [No Abstract]   [Full Text] [Related]  

  • 25. [DERIVATIVES OF 1-(4-HYDROXYPHENYL)-3-PHENYLPROPANOL CONTAINING A BASIC GROUP IN POSITION 2].
    BRAMANTI G; DELLOMODARME G; DIPACO GF
    Farmaco Sci; 1964 Oct; 19():837-48. PubMed ID: 14228405
    [No Abstract]   [Full Text] [Related]  

  • 26. Comprehensive evaluation of lipophilicity of biogenic amines and related compounds using different chemically bonded phases and various descriptors.
    Casoni D; Sârbu C
    J Sep Sci; 2012 Apr; 35(8):915-21. PubMed ID: 22589151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, spectroscopic and structural elucidation of sympathomimetic amine, tyraminium dihydrogenphosphate.
    Kolev TM; Koleva BB; Spiteller M; Sheldrick WS; Mayer-Figge H
    Amino Acids; 2009 Feb; 36(2):185-93. PubMed ID: 18317872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [STUDIES ON THE ABSORPTION OF D, 1-1-(3-HYDROXYPHENYL)-1-HYDROXY-2-ETHYLAMINOETHANE IN THE GASTROINTESTINAL CANAL].
    PROFT D
    Arzneimittelforschung; 1965 Mar; 15():214-5. PubMed ID: 14290815
    [No Abstract]   [Full Text] [Related]  

  • 29. Mosher ester analysis for the determination of absolute configuration of stereogenic (chiral) carbinol carbons.
    Hoye TR; Jeffrey CS; Shao F
    Nat Protoc; 2007; 2(10):2451-8. PubMed ID: 17947986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [OUR EXPERIENCE WITH D,L, 1-(3-HYDROXYPHENYL)-1-HYDROXY-2-ETHYLAMINO-ETHANE HYDROCHLORIDE IN PERIPHERAL VASCULAR SURGERY].
    GUERRA JC; CHADDAD RF; GAIARSA ML; RANIERI FL; AMAURY JN
    Rev Bras Med; 1965 Apr; 22():259-63. PubMed ID: 14339485
    [No Abstract]   [Full Text] [Related]  

  • 31. Sympathomimetic enantiomers and asthma.
    Handley DA; McCullough JR; Crowther SD; Morley J
    Chirality; 1998; 10(3):262-72. PubMed ID: 9499574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [USE OF D, L-1-(3-HYDROXYPHENYL)-1-HYDROXY-2-ETHYLAMINOETHANE HYDROCHLORIDE AS A PREVENTIVE OF HYPOTENSION IN ANESTHESIA].
    AGOSTOFM DE
    Rev Bras Anestesiol; 1964; 14():37-44. PubMed ID: 14126529
    [No Abstract]   [Full Text] [Related]  

  • 33. [CLINICAL EXPERIMENTAL RESULTS OF TESTS WITH DEPOT D, 1-1-(3-HYDROXYPHENYL)-1-HYDROXY-2-ETHYLAMINOETHANE INCLUDING THE USE OF OPHTHALMODYNAMOMETRY].
    MAKABE R
    Arzneimittelforschung; 1965 Mar; 15():216-8. PubMed ID: 14290816
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinico-experimental studies on the effect of dl-1-(4-hydroxyphenyl)-1-hydroxy-2-n-butylaminoethane].
    SPIES R; QUITZOW G; MEISSNER O
    Wien Z Inn Med; 1959 Oct; 40():389-97. PubMed ID: 13833332
    [No Abstract]   [Full Text] [Related]  

  • 35. [ANIMAL EXPERIMENTAL STUDIES ON THE DURATION OF THE EFFECT OF D,1-1-(3-HYDROXYPHENYL)-1-HYDROXY-2-ETHYLMINOETHANE PREPARATIONS].
    DANNEBERG P; HAASE E; HAHN R; SALB R
    Arzneimittelforschung; 1965 Mar; 15():207-13. PubMed ID: 14290814
    [No Abstract]   [Full Text] [Related]  

  • 36. [USE OF RACEMIC 1-(M-HYDROXYPHENYL)-2-ETHYLAMINOETHANOL HC1 CONSIDERED AS A CARDIOVASCULAR ANALEPTIC IN COLLAPSE AND SEVERE HYPOTENSION IN THE COURSE OF MYOCARDIAL INFARCTION].
    FAIVRE G; GILGENKRANTZ JM; CHERRIER F; ROYER R; REBEIX G
    Ann Med Nancy; 1963 Jun; 2():993-1002. PubMed ID: 14067498
    [No Abstract]   [Full Text] [Related]  

  • 37. [The configuration of 1-(3,4-dihydroxyphenyl)-1-hydroxypropan-2-one].
    Ghislandi V; La Manna A; Pratesi P; Villa L
    Farmaco Sci; 1965 Dec; 20(12):829-41. PubMed ID: 5883900
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tentative evaluation of a possible therapeutic action during myopathy. Critical study of the action of p-hydroxyphenyl-butyl-aminoethanol].
    DEMOS J
    Sem Hop; 1963 Mar; 39():572-9. PubMed ID: 14026927
    [No Abstract]   [Full Text] [Related]  

  • 39. ADHD drugs and cardiovascular risk.
    Nissen SE
    N Engl J Med; 2006 Apr; 354(14):1445-8. PubMed ID: 16549404
    [No Abstract]   [Full Text] [Related]  

  • 40. [The place of 1-(m-hydroxyphenyl)-2-(ethylamino)-ethanol hydrochloride in tensio-active therapeutics].
    PEETERS EG
    Scalpel (Brux); 1960 Apr; 113():356-74. PubMed ID: 14431374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.